The addiction treatment industry encompasses residential, outpatient, and intensive outpatient programs (IOP) providing detox, counseling, and medication-assisted treatment (MAT) for substance use disorders. Driven by rising opioid, alcohol, and stimulant addiction rates and expanding insurance parity mandates under the ACA and Mental Health Parity Act, demand for licensed treatment services has grown substantially. The sector remains highly fragmented with thousands of independent operators creating strong consolidation opportunities for strategic and financial buyers.
Who buys these: Private equity-backed behavioral health platforms, regional healthcare operators, licensed clinicians seeking ownership, and strategic acquirers consolidating treatment networks
4–7×
Typical EBITDA multiple
$1M–$5M
Revenue range
Growing
Market trend
SBA Eligible
7(a) financing available
Recession Resistant
Essential service
Minimum $1M EBITDA preferred; licensed and accredited facility (CARF or Joint Commission); clean billing and compliance history; diversified payor mix with at least 30% commercial insurance; stable or growing census; experienced clinical leadership willing to stay post-close
Get Deal Flow In Your Inbox
New Addiction Treatment Center acquisition targets delivered weekly — free to join.
Key items to investigate when evaluating a Addiction Treatment Center acquisition
Seller Intelligence
Who sells Addiction Treatment Center businesses?
Founder-operators and licensed clinicians aged 50–65 looking to retire or reduce operational burden, healthcare entrepreneurs seeking liquidity after building a regional brand, and multi-site operators pruning non-core locations
Typical exit timeline: 12–24 months
Addiction Treatment Center businesses in the $1M–$5M revenue range typically sell for 4–7× EBITDA. Minimum $1M EBITDA preferred; licensed and accredited facility (CARF or Joint Commission); clean billing and compliance history; diversified payor mix with at least 30% commercial insurance; stable or growing census; experienced clinical leadership willing to stay post-close
Addiction Treatment Center businesses typically trade at 4–7× EBITDA in the lower middle market. The market is highly fragmented with growing demand, which supports premium multiples.
Addiction Treatment Center businesses are SBA 7(a) eligible, making them accessible to first-time buyers. Full acquisition with 10–20% seller note and 12–24 month transition earnout tied to census and revenue targets
Key due diligence areas include: State licensing status, accreditation certifications, and any regulatory sanctions or pending investigations; Payor contracts, insurance credentialing, and billing compliance including RAC audit history; Staff credentials, licensure, turnover rates, and key-person dependency on clinical directors; Patient census trends, length-of-stay data, readmission rates, and outcomes reporting; Facility lease terms, physical plant compliance with life safety codes, and any deferred maintenance.
Related Searches
DealFlow OS surfaces acquisition targets, scores seller motivation, and generates outreach — all in one place.
Start finding deals — freeNo credit card required
For Buyers
For Sellers